Thu, July 27, 2017
Wed, July 26, 2017
Tue, July 25, 2017

Carter Gould Maintained (BIIB) at Hold with Increased Target to $285 on, Jul 26th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-285-on-jul-26th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Carter Gould of UBS, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $270 to $285 on, Jul 26th, 2017.

Carter has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


This is the rating of the analyst that currently disagrees with Carter


  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017